Carl B. Feldbaum is Director at EXELIXIS, INC. (EXEL). They have made 13 open-market trades across 1 company since 2016, most recently 2023-02-09.
CIK 0001326377
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EXEL | SELL | 2023-02-09 | 2023-02-10 | $17.78 | $711K | +0.0% | -3.6% | +11.0% |
| EXEL | SELL | 2022-02-22 | 2022-02-24 | $19.49 | $780K | +2.7% | +9.3% | -10.5% |
| EXEL | SELL | 2021-11-19 | 2021-11-23 | $17.62 | $352K | -6.2% | +11.8% | +13.6% |
| EXEL | SELL | 2021-02-16 | 2021-02-17 | $21.96 | $439K | -0.6% | +4.3% | +8.5% |
| EXEL | SELL | 2020-05-07 | 2020-05-08 | $25.02 | $1.6M | -3.4% | -12.6% | -11.9% |
| EXEL | SELL | 2020-03-03 | 2020-03-05 | $18.85 | $1.4M | -21.7% | -6.2% | +23.0% |
| EXEL | SELL | 2019-02-14 | 2019-02-15 | $22.03 | $1.1M | +1.3% | +9.2% | -10.5% |
| EXEL | SELL | 2018-05-30 | 2018-06-01 | $20.60 | $1.4M | -6.5% | +5.2% | -6.3% |
| EXEL | SELL | 2018-03-05 | 2018-03-07 | $23.88 | $263K | -4.8% | -15.6% | -19.9% |
| EXEL | SELL | 2017-05-15 | 2017-05-16 | $21.59 | $302K | -9.2% | -9.8% | +25.4% |
| EXEL | SELL | 2017-05-15 | 2017-05-16 | $21.58 | $712K | -9.2% | -9.8% | +25.4% |
| EXEL | SELL | 2017-03-20 | 2017-03-21 | $21.77 | $218K | +5.4% | +3.7% | +5.1% |
| EXEL | SELL | 2016-12-16 | 2016-12-16 | $17.03 | $426K | -11.3% | +6.0% | +30.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.